4Principi N, Esposito S, Blasi F, et al. Role ofmycoplasma pneumonia and Chlamydia pneumonia in children with community acquired lower respiratory tract infections[ J ]. Clin Infeet Dis, 2001, 32 (9): 1281-9.
5Li M WS, Macfarlane JT, Bos Well TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implicationa for management guidelines [ J ]. Thorax, 2001, 56: 296-301.
6British Thoracic Society Stomdards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults[J]. Thorax, 2001, 56: 1-64.
7Zalacain R, Torres A, Celis R, et al. Community-acquired pneumonia in the eiderly: Spanish multicentre study [J]. J Eur Respir, 2003, 21: 294-302.
8Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Streptococc us pneumoniae [J]. Arch Intern Med, 2000, 160: 1399-408.
9Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
